# 바이오스페이스 일일 뉴스 리포트 - 2025년 10월 23일


## 주요 헤드라인

1. **Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/ipsen-puts-up-1-6b-to-absorb-imcheck-for-mid-stage-leukemia-antibody>

2. **Ipsen Puts Up $1.6B To Absorb ImCheck for Mid-Stage Leukemia Antibody (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/ipsen-puts-up-1-6b-to-absorb-imcheck-for-mid-stage-leukemia-antibody>

3. **Trump To Target Trading Partners With Drug Pricing Probe (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/trump-to-target-trading-partners-with-drug-pricing-probe-report>

4. **Trump To Target Trading Partners With Drug Pricing Probe (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/trump-to-target-trading-partners-with-drug-pricing-probe-report>

5. **ADC, Bispecifics and Kinase Blockers Steal the Spotlight at ESMO 2025 in Berlin (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/adc-bispecifics-and-kinase-blockers-steal-the-spotlight-at-esmo-2025-in-berlin>

6. **Terns Turns Away From Obesity Pill After ‘Uncompetitive’ Phase II Profile (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/terns-turns-away-from-obesity-pill-after-uncompetitive-phase-ii-profile>

7. **Biotech Markets Turn Positive but Experts Say Don’t Call It a Comeback—Yet (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biotech-markets-turn-positive-but-experts-say-dont-call-it-a-comeback-yet>


---
*2025년 10월 23일 바이오스페이스 뉴스 피드에서 생성된 리포트*